News
05-17-2011, 02:21 AM
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reports that surgeons from North Tees and Hartlepool NHS Foundation Trust have presented clinical outcomes using Adipose-Derived Regenerative Cell (ADRC) fat grafting in reconstructive breast surgery at the Association of Breast Surgery Conference in Manchester, UK, May 16-17, 2011. The procedure, referred to by Cytori as RESTORE, was separately investigated in Cytori’s own RESTORE 2 trial.
More... (http://www.news-medical.net/news/20110517/Cytori-Therapeutics-announces-independent-clinical-study-results-in-breast-reconstruction-presented-at-the-Association-of-Breast-Surgery-conference.aspx)
More... (http://www.news-medical.net/news/20110517/Cytori-Therapeutics-announces-independent-clinical-study-results-in-breast-reconstruction-presented-at-the-Association-of-Breast-Surgery-conference.aspx)